Benoît Thibault & Bertrand Jean-Claude. (2017). Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells. BMC.
Tohutoru Kātū Chicago (17th ed.)Benoît Thibault me Bertrand Jean-Claude. Dasatinib + Gefitinib, a Non Platinum-based Combination with Enhanced Growth Inhibitory, Anti-migratory and Anti-invasive Potency Against Human Ovarian Cancer Cells. BMC, 2017.
Tohutoro MLA (9th ed.)Benoît Thibault me Bertrand Jean-Claude. Dasatinib + Gefitinib, a Non Platinum-based Combination with Enhanced Growth Inhibitory, Anti-migratory and Anti-invasive Potency Against Human Ovarian Cancer Cells. BMC, 2017.
Kia tūpato: Kāore pea ēnei kupu hautoa i te ōrite pū 100%.